<!-- markdownlint-disable MD041 MD013 MD032 -->
Look in the `src/utils` directory <!-- ✅ -->

Open the `README.md` file <!-- ✅ -->

Run `./build.sh` to start the build <!-- ✅ -->

Use `print('hello')` for output <!-- ✅ -->

Look in `src/utils/test.js`. <!-- ✅ -->

Run `mycmd(arg1, arg2)` to start <!-- ✅ -->

Find details at https://example.com/path/to/file.js <!-- ✅ -->

Node.js is our runtime <!-- ✅ -->

We support React.js for UI <!-- ✅ -->

Please run tests in CI/CD <!-- ✅ -->

Use abbreviations like e.g. and i.e. <!-- ✅ -->

Our code uses import/export syntax <!-- ✅ -->

See https://semver.org/spec/v2.0.0.html for details <!-- ✅ -->

- **Headings/titles**: Use **sentence case** (e.g., `Mental models in decision-making`) <!-- ✅ -->

> ![[Engelbart.jpg]] <!-- ✅ -->
> If you're also using the Admonitions plugin, you should update it to at least version 8.0.0 to avoid problems with the new callout feature. <!-- ✅ -->

- `--callout-icon` can be an icon ID from [lucide.dev](https://lucide.dev), or an SVG element. <!-- ✅ -->
![[Engelbart.jpg#outline]] <!-- ✅ -->
![[Engelbart.jpg#outline|100]] <!-- ✅ -->

> ![[link-block-heading.png#interface]] <!-- ✅ -->

- `[Custom name](Example.md)` appears as [Custom name](Example.md) <!-- ✅ -->
- `[Section name](Example.md#Details)` appears as [Section name](Example.md#Details) <!-- ✅ -->

> ![[internal-links-header.png#interface]] <!-- ✅ -->
You can add properties to [[Plugins/Templates]]. When you insert a template into the active note, all the properties from the template will be added to the note. Obsidian will also merge any properties that exist in your note with properties in the template. <!-- ✅ -->

- [personal-alignment-tracker](personal-alignment-tracker.md) <!-- ✅ -->
- [schwartz-basic-human-values](schwartz-basic-human-values.md) <!-- ✅ -->
- [midjourney-reports](midjourney-reports.md) <!-- ✅ -->
- [schwartz-values-table](schwartz-values-table.md) <!-- ✅ -->
- [christen-values-table](christen-values-table.md) <!-- ✅ -->
![Surveys.png](./assets/Surveys.png) <!-- ✅ -->
![Surveys-2.png](./assets/Surveys-2.png) <!-- ✅ -->
[Schwartz Values - Desk Reference - 15APR2019.pdf](./assets/789BFFB7-6895-4E0E-85C2-F4EB4BBF2E22_2.pdf) <!-- ✅ -->
[SSPOFADV.pdf](./assets/SSPOFADV.pdf) <!-- ✅ -->
![Image.png](./assets/CD231382-F900-4897-9701-938B9F030888_2.png) <!-- ✅ -->
![Screenshot 2024-07-05 at 10.27.41 PM.png](./assets/Screenshot%202024-07-05%20at%2010.27.41%20PM.png) <!-- ✅ -->
- **Semi-Retirement**: You work part-time, covering the shortfall of $16,716.79 with part-time income, while still withdrawing enough to cover annual expenses ($19,283.21). <!-- ✅ -->
- **Full Retirement**: You withdraw $41,183.44 annually to cover expenses, ensuring the savings draw down to zero by age 100. <!-- ✅ -->
- **Annual Withdrawal Post-Retirement (Age 56 to 100)**: $41,183.44 <!-- ✅ -->
[Summary Plan Descriptions.pdf](./assets/7A102BCC-42C1-4B8B-A62B-A7578B6A62A5_2.pdf) <!-- ✅ -->
**414(k)**, governed by **401(a)**, complies with **404(c)** <!-- ✅ -->
Roth **403(b)**, maximum contribution, deducted from base pay <!-- ✅ -->
$433.72 per pay period into your Schwab brokerage account, invested using Schwab intelligent portfolios. <!-- ✅ -->
[benefit-calculator-estimates.pdf](./assets/C1D76619-CA0D-4804-B5BB-67C8FA58D911_2.pdf) <!-- ✅ -->
[songcrunch.shinyapps.io](https://songcrunch.shinyapps.io/coastfire/) <!-- ✅ -->
- 2.5% wage growth <!-- ✅ -->
- $3,500/month retirement living expenses <!-- ✅ -->
Called to refill Xeljanz. Found I have a $4810.30 balance. Rep from Accredo says this is from March 2023, when only $100 was covered. This was after I had sorted out all the issues last year. <!-- ✅ -->
| **Date**   | **Iron Total (ug/dL)** | **Lower Ref Range (ug/dL)** | **Upper Ref Range (ug/dL)** | <!-- ✅ -->
- [health/ulcerative-colitis](health/ulcerative-colitis.md) <!-- ✅ -->
- **Improvement**: Incorporate the 90/90 drill, which mobilizes various hip muscles. <!-- ✅ -->
For more comprehensive guidance, including how to balance muscle building and lean-down efficiently without neglecting mobility and prehab, consider exploring tailored programs like those offered at [BuiltWithScience.com](http://BuiltWithScience.com). Remember to support your fitness journey by subscribing to channels that offer valuable insights and updates. <!-- ✅ -->
![Photo from Library.jpeg](./assets/8DF7B81D-7C37-41EA-B9E7-C5C0D9583824_2.jpeg) <!-- ✅ -->
- [health/hereditary-hemochromatosis](health/hereditary-hemochromatosis.md) <!-- ✅ -->
- Far PD (Pupillary Distance): 65.5 mm <!-- ✅ -->
- Near PD: 63.3 m <!-- ✅ -->
- **Bupropion (Wellbutrin 100/150 mg)** – Alternating doses daily for mood stabilization and depression. <!-- ✅ -->
| **Date**   | **Globulin (g/dL)** | **Reference Range (g/dL)** | **ALBUMIN/GLOBULIN RATIO** | <!-- ✅ -->
| 2023-01-06 | 1.8                 | 1.9-3.7                    | 2.7*                       | <!-- ✅ -->
- [health/covid-and-long-covid](health/covid-and-long-covid.md) <!-- ✅ -->
| 2023-02-07 | 1.9                 | 2.2-4.2                    | \-                         | <!-- ✅ -->
- [health/mental-health](health/mental-health.md) <!-- ✅ -->
- [health/musculoskeletal-and-posture](health/musculoskeletal-and-posture.md) <!-- ✅ -->
**Date:** 3/4/2024 3:00 PM <!-- ✅ -->
**DOB:** 5/14/1985 <!-- ✅ -->
**Date of Consultation:** 3/4/2024 <!-- ✅ -->
**Reason for Consult/Chief Complaint:** Evaluation and management of iron overload from newly diagnosed hereditary hemochromatosis with compound heterozygosity for C282Y/H63D in HFE gene <!-- ✅ -->
38-year-old male with a history of anxiety/depression and ulcerative colitis/proctitis (diagnosed in 2009, currently on tofacitinib) was found to have elevated iron levels. Subsequent HFE genetic testing in 11/2023 demonstrated compound heterozygosity for C282Y/H63D. Mr. Casciano presents to BWH hematology clinic for further evaluation and management. <!-- ✅ -->
His elevated serum iron was first noted on 2/7/23 (198 with Tsat 81% and ferritin 325). His mother was diagnosed with hereditary hemochromatosis. Subsequent iron panels showed a ferritin of 273 and serum iron of 188 in 11/2023, leading to HFE genetic testing on 11/14/23, which confirmed compound heterozygosity for C282Y/H63D. He was referred to hematology for management. <!-- ✅ -->
| Colonoscopy                 | N/A               | 11/16/2023 | <!-- ✅ -->

2. **Vice-like headache was salient symptom during Covid infection, and remained recurrent after COVID. Now occurs maybe half the time, pain severity 4-7/10.** <!-- ✅ -->
**Allergies as of 03/04/2024:** <!-- ✅ -->

- **Packs/day:** 0.25 <!-- ✅ -->
- **Years:** 6.00 <!-- ✅ -->
- **Additional pack years:** 0.00 <!-- ✅ -->
- **Total pack years:** 1.50 <!-- ✅ -->
- **Alcohol/week:** 3 standard drinks (3 glasses of wine per week) <!-- ✅ -->
Except as noted above, the 10-point review of systems is negative. The patient's medical history has been reviewed in detail with no changes to the history noted in the electronic medical record. Review of systems, physical exam, and assessment and plan reviewed and/or performed on 3/4/2024 with no changes except as documented. <!-- ✅ -->
**Vitals (03/04/24 1503)** <!-- ✅ -->
- BP: 130/72 <!-- ✅ -->
**Lab Results (03/04/2024)** <!-- ✅ -->
| WBC           | 4.82      | <!-- ✅ -->
| RBC           | 4.73      | <!-- ✅ -->
| HGB           | 15.1      | <!-- ✅ -->
| HCT           | 43.5      | <!-- ✅ -->
| MCV           | 92.0      | <!-- ✅ -->
| MCH           | 31.9      | <!-- ✅ -->
| MCHC          | 34.7      | <!-- ✅ -->
| RDW           | 12.1      | <!-- ✅ -->
| MVP           | 10.9      | <!-- ✅ -->
| NRBCA         | 0.00      | <!-- ✅ -->
| NEUT          | 71.4      | <!-- ✅ -->
| LYMP          | 15.6 (L)  | <!-- ✅ -->
| MON           | 11.6 (H)  | <!-- ✅ -->
| EOSP          | 0.6       | <!-- ✅ -->
| ANEU          | 3.44      | <!-- ✅ -->
| ALYMP         | 0.75      | <!-- ✅ -->
| AMONS         | 0.56      | <!-- ✅ -->
| AEOSN         | 0.03      | <!-- ✅ -->
| ABASOP        | 0.02      | <!-- ✅ -->
**Additional Lab Results (03/04/2024)** <!-- ✅ -->
**HFE Genetic Testing (11/14/23)** <!-- ✅ -->
38-year-old male with a history of anxiety/depression, ulcerative colitis/proctitis (diagnosed in 2009, on tofacitinib), found to have elevated iron levels with HFE genetic testing in 11/2023 demonstrating compound heterozygosity for C282Y/H63D, presents to BWH hematology clinic for further evaluation and management of newly diagnosed hereditary hemochromatosis. <!-- ✅ -->
Today, we reviewed Mr. Casciano's prior iron studies, which show mildly elevated ferritin between 273-375 throughout 2023 with an elevated Tsat of 81%. Ferritin can be elevated due to iron overload or as an acute phase reactant in the setting of his underlying inflammatory bowel disease. Tsats may also be elevated following recent meal ingestion. However, HFE genetic testing demonstrated he is compound heterozygous for C282Y/H63D, consistent with hereditary hemochromatosis. <!-- ✅ -->
- Iron levels: Elevated over time, latest 198ug/dL on Feb 7, 2023 (reference range: 37 - 158 ug/dL). <!-- ✅ -->
5/14/1985 <!-- ✅ -->
- Globulin: Low at 1.9g/dL on Feb 7, 2023 (reference range: 2.2 - 4.2 g/dL). <!-- ✅ -->
1/6/2023 4:19 PM <!-- ✅ -->
1/6/2023 4:32 PM <!-- ✅ -->
- According to Dynamed, "hereditary hemochromatosis confirmed with **compound heterozygous (C282Y/H63D) sequences.** <!-- ✅ -->
Dictated: 01/06/2023 4:32 PM <!-- ✅ -->
- Vitamin D deficiency: Level 11 on 1/17 <!-- ✅ -->
**Collected:** 1/19/2024 12:30 PM (EST) <!-- ✅ -->
**Reported:** 1/19/2024 1:14 PM <!-- ✅ -->
- **Extrahepatic Ducts:** Normal. Common duct diameter: 0.2 cm <!-- ✅ -->
- **Right Kidney:** Normal, measures 10.9 cm in length. <!-- ✅ -->
- Exercise: 1-2 times per week, daily dog walking, ~75% achievement of recommended 150 minutes/week; includes runs/yoga/strength training. <!-- ✅ -->
**Dictated:** 01/19/2024 1:14 PM <!-- ✅ -->
- Tobacco, alcohol, recreational drugs: No alcohol or tobacco; cannabis vaping or oil 1-2 times/week. <!-- ✅ -->
**Date:** 05/07/24 <!-- ✅ -->
**Title:** FibroScan Results: 10.6 kPa <!-- ✅ -->
**Electronically signed by:** Meredith Rourke, RN on 05/07/24 at 9:18 PM <!-- ✅ -->
**Electronically cosigned by:** Michael P. Curry, MD on 05/09/24 at 10:07 AM <!-- ✅ -->
- **BMI:** 21.8 kg/m² <!-- ✅ -->
- **FibroScan Score:** 10.6 kPa <!-- ✅ -->
- **FibroScan IQR/med:** 7% <!-- ✅ -->
- **CAP Score:** 201 dB/m <!-- ✅ -->
- [ ] What potential side effects should I be aware of with my current medication/treatment? <!-- ✅ -->
- Excision of right shoulder lipoma (8/8/17) <!-- ✅ -->
- Flexible Sigmoidoscopy (3/12/18): Inflammation in the rectum, worse from the prior examination. <!-- ✅ -->
Invoice from 8/25/2022 ($4,690.94) won't open, the others will. (Same for me on Express-Scripts website) <!-- ✅ -->
Prescription Drug Coverage Your prescription drug benefit is included with your medical plan premium and is administered by Express Scripts, a pharmacy benefits manager. Upon initial enrollment in a Harvard-sponsored medical plan, you will receive instructions for prescription drug services. Prescription drug coverage has three copayment tiers, with most generic medications having the lowest copayment. Prescription copayment assistance is available and administered by PillarRx for certain specialty medications filled through one of the Harvard-sponsored medical plans (does not include D.C. medical plans). If you are prescribed an eligible medication, you will be contacted by PillarRx to facilitate enrollment in the manufacturer programs. Manufacturer assistance dollars will not accumulate toward deductibles and/or out-of-pocket maximums. To use the program, you must engage with PillarRx to enroll. For more details, please visit [hr.harvard.edu/medical](http://hr.harvard.edu/medical). <!-- ✅ -->
$666.05 <!-- ✅ -->
$4,332.10 Remaining <!-- ✅ -->
- Mother: Anxiety/depression, hemachromotosis (treated with phlebotomy) <!-- ✅ -->
Jan 1 21 to 6/30/22, prior auth is what you gave me low cost. <!-- ✅ -->
1/1/21 – 6/30/22 <!-- ✅ -->
- Vice-like headaches (persistent, severity 4-7/10). <!-- ✅ -->
Hereditary Hemochromatosis (HH) diagnosed in 2023 with compound heterozygosity for C282Y/H63D mutations in the HFE gene. <!-- ✅ -->
- **HFE Genetic Testing (2023)** – Compound heterozygosity for C282Y/H63D confirmed. <!-- ✅ -->
- **Bloodwork (2023-2024)** – Elevated serum iron (198 ug/dL), transferrin saturation (81%), and ferritin levels (273-375). <!-- ✅ -->
- **FibroScan (2024)** – Score of 10.6 kPa consistent with Metavir Stage 3 fibrosis, indicating moderate liver scarring. No signs of cirrhosis. <!-- ✅ -->
![20211901116-20211901521-GOES16-ABI-NE-Sandwich-600x600.gif](./assets/20211901116-20211901521-GOES16-ABI-NE-Sandwich-600x600.gif) <!-- ✅ -->
![20211901116-20211901521-GOES16-ABI-NE-GEOCOLOR-600x600.gif](./assets/20211901116-20211901521-GOES16-ABI-NE-GEOCOLOR-600x600.gif) <!-- ✅ -->
![Elsa_2021_track.png](./assets/Elsa_2021_track.png) <!-- ✅ -->
![IMG_0778.jpeg](./assets/F01F65C9-94BB-4B78-B593-D690DA5269BC_2.jpeg) <!-- ✅ -->
![IMG_0777.jpeg](./assets/61D6834B-051C-4777-98E6-91E5F27C0865_2.jpeg) <!-- ✅ -->
![IMG_0776.jpeg](./assets/66B41A62-2D2A-428A-A5C6-ABFAC05C8E57_2.jpeg) <!-- ✅ -->
![IMG_0774.jpeg](./assets/470985E7-D864-4673-A2AA-03FC58A36159_2.jpeg) <!-- ✅ -->
![IMG_0786.jpeg](./assets/E4F7744B-7271-4764-A6B3-2555921BC4B4_2.jpeg) <!-- ✅ -->
![IMG_0785.jpeg](./assets/A49C3BAC-412B-4994-B458-E5B1B00D7107_2.jpeg) <!-- ✅ -->
![IMG_0787.jpeg](./assets/6BD238C5-1D37-498D-9833-EA5404318F16_2.jpeg) <!-- ✅ -->
![IMG_0789.jpeg](./assets/BE11F930-72D5-45CB-BD8A-0C470ADBDE95_2.jpeg) <!-- ✅ -->
![2AFAF5A1-1EAD-4EBA-A9F5-D83783869532_1_105_c.jpeg](./assets/647CE907-0D1E-4DD2-875D-F3AE0ECB2117_2.jpeg) <!-- ✅ -->
![634C0046-0C08-42F3-A71C-20F332AB6E1B_1_105_c.jpeg](./assets/539E737C-6C51-4A8C-91E0-58F95957A0F2_2.jpeg) <!-- ✅ -->
![327F8985-4F33-4B7F-B0C8-654099A21426_1_105_c.jpeg](./assets/7EF4A75A-A3B7-41E5-BD3D-0AD00A8D7644_2.jpeg) <!-- ✅ -->
![74ACDD01-70B3-4943-9CDA-4A9FF9F90978_1_105_c.jpeg](./assets/510D2B43-C592-4EEB-B081-98172412E674_2.jpeg) <!-- ✅ -->
![2CB8384F-D88A-4681-81CD-0F05615ED84B_1_105_c.jpeg](./assets/8950D987-E84F-466E-B185-FEB7EF0E8890_2.jpeg) <!-- ✅ -->
![C4D44E45-DE1D-410E-B34C-87D4515085A1_1_105_c.jpeg](./assets/F025F527-8476-47BC-AC96-FE3CEC04E9C6_2.jpeg) <!-- ✅ -->
![96BBAA42-9654-4136-A42B-5F345038FC1C_1_105_c.jpeg](./assets/C7D5C094-A784-4E94-B2FB-C3CDD6E98AAE_2.jpeg) <!-- ✅ -->
![Photo from Library.jpeg](./assets/9B070228-2612-40D0-809D-64B29C09715E_2.jpeg) <!-- ✅ -->
![Dame-Pankhurst_black_light_William_Morris_pattern_de517b10-10ed-49f4-a519-435fb103d2b0.png](./assets/Dame-Pankhurst_black_light_William_Morris_pattern_de517b10-10ed-49f4-a519-435fb103d2b0.png) <!-- ✅ -->
![030310_1350926.png.2000x1340_q95_crop-smart_upscale.png](./assets/23256DF1-2E49-4D02-8600-3ECD350C8C2D_2.png) <!-- ✅ -->
![Ori-Howl-2-1024x576.png](./assets/627E0C0B-FE37-43F3-80DD-531E1CB1B49F_2.png) <!-- ✅ -->
![Image.tiff](./assets/Image.tiff) <!-- ✅ -->
![kynoptic_ancient_greek_man_a28e66c9-24b5-4e9c-83b2-57401c364025.png](./assets/kynoptic_ancient_greek_man_a28e66c9-24b5-4e9c-83b2-57401c364025.png) <!-- ✅ -->
![kynoptic_ancient_greek_furry_character_8f14c479-5d66-48e2-812b-bad06e85beaa.png](./assets/kynoptic_ancient_greek_furry_character_8f14c479-5d66-48e2-812b-bad06e85beaa.png) <!-- ✅ -->
![kynoptic_ancient_greek_furry_character_e79d1d1f-057a-4ef7-9b78-28374bfeea8c.png](./assets/kynoptic_ancient_greek_furry_character_e79d1d1f-057a-4ef7-9b78-28374bfeea8c.png) <!-- ✅ -->
![kynoptic_The_Charioteer_of_Delphi_ad71fef5-e437-4e11-b1a0-d86119564fa4.png](./assets/kynoptic_The_Charioteer_of_Delphi_ad71fef5-e437-4e11-b1a0-d86119564fa4.png) <!-- ✅ -->
![kynoptic_An_expansive_landscape_photograph_reminiscent_of_Eliot_2c754dce-fdce-4312-99fe-f91c60809f61.png](./assets/kynoptic_An_expansive_landscape_photograph_reminiscent_of_Eliot_2c754dce-fdce-4312-99fe-f91c60809f61.png) <!-- ✅ -->
![kynoptic_A_raw_photojournalistic_image_reminiscent_of_Annie_Lei_b9821995-9807-4a33-b048-202809eeb120.png](./assets/kynoptic_A_raw_photojournalistic_image_reminiscent_of_Annie_Lei_b9821995-9807-4a33-b048-202809eeb120.png) <!-- ✅ -->
![kynoptic_Animated_film_still_of_Oracle_of_Delphi_by_Hayao_Miyaz_a8855612-5f81-4ac6-8df5-96ab360ae530.png](./assets/kynoptic_Animated_film_still_of_Oracle_of_Delphi_by_Hayao_Miyaz_a8855612-5f81-4ac6-8df5-96ab360ae530.png) <!-- ✅ -->
![6726bb75-9b2f-4774-a83c-8bc6b511640b.png](./assets/D3859DFC-1AEB-4CFA-8AA0-A69F49414060_2.png) <!-- ✅ -->
![IMG_2175.jpeg](./assets/7126ACD2-B3D3-4663-896C-0017A4596696_2.jpeg) <!-- ✅ -->

2. I cherish the time spent with my dog during our walk. His/her presence and love offer a wonderful escape from the stresses of life. <!-- ✅ -->
![IMG_2210.heic](./assets/216BE622-A5B2-48E1-852F-99FADB754A48_2.heic) <!-- ✅ -->
![IMG_3420.heic](./assets/E9574D67-CA93-4D23-92C2-CF7786ED374C_2.heic) <!-- ✅ -->
![IMG_2208.jpeg](./assets/05470DA4-68CA-43A0-A886-9AA3F198145A_2.jpeg) <!-- ✅ -->
![IMG_2207.jpeg](./assets/3F4286FF-9B1C-40C7-A253-35BF2AD5BCC8_2.jpeg) <!-- ✅ -->
![IMG_2204.jpeg](./assets/982FE427-4317-43A7-832C-188A4257D301_2.jpeg) <!-- ✅ -->
![IMG_2202.jpeg](./assets/FE8257EE-A755-4D24-B12C-D17B099B9220_2.jpeg) <!-- ✅ -->
![IMG_2200.jpeg](./assets/09179B8E-2696-4280-98F2-3B6322F1E4D8_2.jpeg) <!-- ✅ -->
![IMG_2198.jpeg](./assets/E4201A74-55C9-47DC-9A43-7ECC8FF0B904_2.jpeg) <!-- ✅ -->
![IMG_2285.jpeg](./assets/FE671154-38B0-453E-9AC3-2515369871A2_2.jpeg) <!-- ✅ -->
![IMG_2284.jpeg](./assets/BCBB294F-6769-4343-A309-4D935EF97A10_2.jpeg) <!-- ✅ -->
![IMG_0182.jpeg](./assets/526469CC-FDE6-4D9E-A172-1427575615A8_2.jpeg) <!-- ✅ -->
![Image.png](./assets/71755A16-3DB6-44B9-A83F-0AED81688E3B_2.png) <!-- ✅ -->
![kynoptic_Curtains_of_Suspense_Film_still_photograph_capturing_s_2f0ff26d-61db-42d7-8931-067a01f0b160.png](./assets/A9C4C20A-8338-44E8-94CB-630207118CBC_2.png) <!-- ✅ -->

- **Bracelet length** – 6.75 inches <!-- ✅ -->
| 2001-09-11            |                     | 🇺🇸      | 9/11 terrorist attacks                                                   | World Events       | <!-- ✅ -->
The Extended Date/Time Format (EDTF) extends the traditional date and time representations found in various date formats. It builds upon the widely used ISO 8601 standard, which specifies the format for representing dates and times. It is included in ISO 8601-2:2019. <!-- ✅ -->
- **Occupational History:** Works in communication for Harvard Medical School. Family ancestry is half Sicilian, half German/northern European. No children. Has two siblings. Mother has hereditary hemochromatosis. <!-- ✅ -->
Monica Wood, M.D. <!-- ✅ -->
Lines/Tubes:   None. <!-- ✅ -->
Lungs/Pleura:   The lungs are well inflated.   There is no focal consolidation or pulmonary edema.   There is no pleural effusion or pneumothorax. <!-- ✅ -->
Heart/Mediastinum:   The cardiomediastinal silhouette is unremarkable. <!-- ✅ -->
Bones/Soft Tissues:   The bones and soft tissues are unremarkable for age. <!-- ✅ -->
Signed by: Monica Wood, M.D. <!-- ✅ -->
**Exam:** Ultrasound, Abdominal, Limited, Single Organ/Quadrant <!-- ✅ -->
- Father: High cholesterol, anxiety/depression <!-- ✅ -->
Use the and/or operator in logic. <!-- ✅ -->
A/B testing improves results. <!-- ✅ -->
